{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T06:27:31Z","timestamp":1787120851106,"version":"build-2736575974"},"reference-count":31,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Biobanks accelerate\n                      <jats:italic>in vitro<\/jats:italic>\n                      diagnostic (IVD) clinical trials by providing annotated, quality-controlled biospecimens. However, a persistent translational gap remains because the specific requirements of IVD trials\u2014including sample matrices, preservation protocols, aliquot volumes, freeze\u2013thaw tolerability, and clinical metadata\u2014have not been systematically characterized. This study aims to establish an evidence-based framework to align infectious disease biobanking operations with regulatory-grade IVD trial demands by systematically characterizing the specimen preservation parameters and clinical metadata requirements of IVD trials.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We retrospectively analyzed 140 infectious disease IVD trials (covering HIV\/AIDS, COVID-19, viral hepatitis, and tuberculosis) conducted at a major Chinese infectious disease center between 2018 and 2025. Using a standardized extraction protocol, we systematically evaluated specimen preservation parameters (sample type, aliquot volume, storage temperature, duration, and freeze\u2013thaw cycles), clinical metadata elements (universal and disease-specific), and control sample requirements.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum\/plasma was the primary matrix (75.7% of trials), followed by whole blood (20.0%), sputum (13.6%), and swabs (10.7%). Predominant aliquot volumes were 0.5\u20131.0\u202fmL for serum\/plasma (52% of trials), 0.1\u20130.5\u202fmL for whole blood (66%), and 2.0\u20133.0\u202fmL for sputum (50%). Most trials preferred frozen specimens (48.6% exclusively frozen; 37.9% accepting both). For short-term preservation (2 \u00b0C\u20138 \u00b0C), a 7-day window was acceptable in 56% of serum\/plasma protocols; for long-term preservation, \u221270 \u00b0C was required for 80% of serum\/plasma and 100% of sputum samples. Strict freeze\u2013thaw avoidance was mandated in 64% of serum\/plasma, 72% of whole blood, and 60% of swab protocols. Core metadata (sample type and clinical diagnosis) were universally recorded (100%), whereas disease-specific laboratory parameters and control sample showed marked variation across disease categories.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This single-center analysis offers preliminary evidence for a framework to standardize infectious disease biobanking practices tailored to IVD clinical trials. Implementation of the proposed preservation guidelines and tiered metadata framework, including standardized aliquot volumes, temperature-dependent storage protocols, strict freeze\u2013thaw limitations, and strategic accrual of diverse control specimens, has the potential to optimize specimen utility, accelerate diagnostic development, and strengthen outbreak preparedness. However, external validation through multicenter studies is needed before these recommendations can be generalized to other settings.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fpubh.2026.1903960","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:46:24Z","timestamp":1787118384000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Evidence-based standardization of infectious disease biobanking: aligning specimen preservation and clinical metadata with in vitro diagnostic clinical trials requirements"],"prefix":"10.3389","volume":"14","author":[{"given":"Chao","family":"Xia","sequence":"first","affiliation":[{"name":"Biobank, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjian","family":"Liao","sequence":"additional","affiliation":[{"name":"Biobank, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sen","family":"Yang","sequence":"additional","affiliation":[{"name":"Biobank, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Cheng","sequence":"additional","affiliation":[{"name":"Biobank, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Qi","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ouyang","sequence":"additional","affiliation":[{"name":"Clinical Research Center, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bangyan","family":"Guan","sequence":"additional","affiliation":[{"name":"Department of Nursing, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yemiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Biobank, Chongqing Public Health Medical Center","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/s41579-021-00639-z","article-title":"Infectious disease in an era of global change","volume":"20","author":"Baker","year":"2022","journal-title":"Nat Rev Microbiol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"1009393","DOI":"10.3389\/fpubh.2022.1009393","article-title":"COVID-19 outbreak: impact on global economy","volume":"10","author":"Naseer","year":"2022","journal-title":"Front Public Health"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1016\/s2352-3018(25)00270-x","article-title":"Global HIV prevention is not on track: how a health systems approach can promote sustainable progress in African countries","volume":"13","author":"Matanje","year":"2026","journal-title":"Lancet HIV"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"e1005114","DOI":"10.1371\/journal.pmed.1005114","article-title":"Differences in tuberculosis prevalence by sex in low- and middle-income countries over 1993-2025: a systematic review and meta-analysis","volume":"23","author":"Swartwood","year":"2026","journal-title":"PLoS Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"gutjnl-2025-337838","DOI":"10.1136\/gutjnl-2025-337838","article-title":"Hepatocellular carcinoma attributable to hepatitis B, hepatitis C and other risk factors at global, regional and national levels: an updated systematic review and meta-analysis","author":"Cao","year":"2026","journal-title":"Gut"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1021\/acs.accounts.1c00367","article-title":"Lab-on-a-disc for point-of-care infection diagnostics","volume":"54","author":"Sunkara","year":"2021","journal-title":"Acc Chem Res"},{"key":"ref7","year":"2021"},{"key":"ref8","year":"2024"},{"key":"ref9","year":"2025"},{"key":"ref10","year":"2024"},{"key":"ref11","year":"2026"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1177\/19475535251391616","article-title":"Lessons learned in clinical trial recruitment: a partnership between a genomic research study and the discover together biobank","volume":"24","author":"Childers-Buschle","year":"2025","journal-title":"Biopreserv Biobank"},{"key":"ref13","year":"2022"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1089\/bio.2018.0001","article-title":"The 2018 revision of the ISBER best practices: summary of changes and the editorial team's development process","volume":"16","author":"Campbell","year":"2018","journal-title":"Biopreserv Biobank"},{"key":"ref15","article-title":"Test Order: Polio Serology- CLIA (CDC-10377)","year":""},{"key":"ref16","volume-title":"Measures for Ethical Review of Life Science and Medical Research Involving Humans","year":"2023"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/978-981-96-7097-0_3","volume-title":"Molecular Diagnostics for Viral Diseases: Challenges and Emerging Concepts","author":"Singh","year":"2025"},{"key":"ref18","volume-title":"Laboratory Diganosis of tuberculosis by Sputum Microscopy: the Handbook, Global edition","year":"2013"},{"key":"ref19","volume-title":"Diagnostic Testing for SARS-CoV-2. Diagnostic Testing for SARS-CoV-2","year":"2020"},{"key":"ref20","year":"2024"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1177\/19475535251392783","article-title":"Evaluating decisions on primary sample aliquot volumes based on experience of utilization: recommendations for today's biobanks","volume":"24","author":"McDonald","year":"2026","journal-title":"Biopreserv Biobank"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"e0294743","DOI":"10.1371\/journal.pone.0294743","article-title":"The ASPREE healthy ageing biobank: methodology and participant characteristics","volume":"19","author":"Parker","year":"2024","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"728273","DOI":"10.3389\/fmolb.2021.728273","article-title":"Integrating whole blood transcriptomic collection procedures into the current anti-doping testing system, including long-term storage and re-testing of anti-doping samples","volume":"8","author":"Lima","year":"2021","journal-title":"Front Mol Biosci"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"4428","DOI":"10.1021\/acs.jproteome.0c00537","article-title":"Quantitative in-vitro diagnostic NMR spectroscopy for lipoprotein and metabolite measurements in plasma and serum: recommendations for analytical artifact minimization with special reference to COVID-19\/SARS-CoV-2 samples","volume":"19","author":"Loo","year":"2020","journal-title":"J Proteome Res"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1089\/bio.2022.0004","article-title":"Evaluating the effects of storage conditions on multiple cell-free RNAs in plasma by high-throughput sequencing","volume":"21","author":"Sun","year":"2023","journal-title":"Biopreserv Biobank"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-026-54454-8","article-title":"Analysis of purines and pyrimidines across biospecimens: influence of storage temperature and duration","author":"Wurth","year":"2026","journal-title":"Sci Rep"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s11306-025-02259-7","article-title":"Recommendations for sample selection, collection and preparation for NMR-based metabolomics studies of blood","volume":"21","author":"Emwas","year":"2025","journal-title":"Metabolomics"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1002\/jcla.21904","article-title":"Long-term storage at \u221280\u00b0C: effect on rate of recovery of Mycobacterium tuberculosis from direct acid-fast Bacilli smear-positive sputum samples","volume":"30","author":"Shinu","year":"2016","journal-title":"J Clin Lab Anal"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"e20122","DOI":"10.7717\/peerj.20122","article-title":"Quality assessment from biobank plasma and serum specimens: a systematic review","volume":"13","author":"Liang","year":"2025","journal-title":"PeerJ"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1089\/bio.2012.0003","article-title":"A minimum data set for sharing biobank samples, information, and data: MIABIS","volume":"10","author":"Norlin","year":"2012","journal-title":"Biopreserv Biobank"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1089\/bio.2019.0129","article-title":"Extending the minimum information about BIobank data sharing terminology to describe samples, sample donors, and events","volume":"18","author":"Eklund","year":"2020","journal-title":"Biopreserv Biobank"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1903960\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T05:46:25Z","timestamp":1787118385000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1903960\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,19]]},"references-count":31,"alternative-id":["10.3389\/fpubh.2026.1903960"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1903960","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,19]]},"article-number":"1903960"}}